These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1729960)

  • 1. [A study of combination chemotherapy (BHAC-ACVP) for adult acute lymphocytic leukemia. Hanshin Co-operative Study Group of Hematological Malignancies].
    Kanamaru A; Kakishita E; Nagai K; Masaoka T; Horiuchi A; Kitani T; Yasunaga K; Kawagoe H; Tatsumi N; Kageyama T
    Gan To Kagaku Ryoho; 1992 Jan; 19(1):49-54. PubMed ID: 1729960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Multi-agent combination chemotherapy for adult acute lymphoblastic leukemia--individualized chemotherapy].
    Uzuka Y; Saito Y; Takahashi H; Komatsu M; Ito T; Toyota T
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1917-23. PubMed ID: 2393309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphocytic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen.
    Weiser MA; Cabanillas ME; Konopleva M; Thomas DA; Pierce SA; Escalante CP; Kantarjian HM; O'Brien SM
    Cancer; 2004 Mar; 100(6):1179-85. PubMed ID: 15022284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term follow-up results of hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone (Hyper-CVAD), a dose-intensive regimen, in adult acute lymphocytic leukemia.
    Kantarjian H; Thomas D; O'Brien S; Cortes J; Giles F; Jeha S; Bueso-Ramos CE; Pierce S; Shan J; Koller C; Beran M; Keating M; Freireich EJ
    Cancer; 2004 Dec; 101(12):2788-801. PubMed ID: 15481055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Results of the CCLSG high risk ALL 874 protocol in childhood acute lymphoblastic leukemia. Children's Cancer and Leukemia Study Group].
    Kawai S; Fujimoto T; Zha Z; Asami K; Oka T; Kaneko Y; Takaue Y; Ninomiya T; Nishikawa K; Tsuchiya T
    Rinsho Ketsueki; 1993 Feb; 34(2):128-36. PubMed ID: 8492409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of adult acute lymphoblastic leukemia by KHALL-93--long-term outcome].
    Usuki K; Adachi Y; Kazama K; Iki S; Urabe A
    Gan To Kagaku Ryoho; 2000 Aug; 27(9):1397-402. PubMed ID: 10969595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of acute lymphoblastic leukemia in children with AL90 regimen: impact of response to treatment and sex difference on prognostic factors.
    Ishii E; Eguchi H; Matsuzaki A; Koga H; Yanai F; Kuroda H; Kawakami K; Ayukawa H; Akiyoshi K; Kamizono J; Tamai Y; Kinukawa N; Okamura J
    Med Pediatr Oncol; 2001 Jul; 37(1):10-9. PubMed ID: 11466717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].
    Meng FY; Yang LJ; Xu B; Liu XL; Zheng WY; Zhang Y; Huang F; Sun J; Liu QF
    Ai Zheng; 2003 Dec; 22(12):1330-3. PubMed ID: 14693062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment and prognosis after late relapse in childhood acute lymphoblastic leukemia].
    Ikuta K; Fujioka K; Takahashi H; Sumita H; Sekiguchi H; Hanzawa N; Kai S; Kajigaya Y; Funabiki T; Okuyama T
    Rinsho Ketsueki; 1993 Jun; 34(6):712-7. PubMed ID: 8366572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Multicenter randomized control trial on safety of domestic idarubicin for acute leukemia].
    Liu Y; Ke XY; Ma J; Shen ZX; Zhang XH; Du X; Zhao YM; Lv JQ; Zhan ZM; Zeng XY; Xu XH; Lu ZS
    Zhonghua Zhong Liu Za Zhi; 2006 Sep; 28(9):706-8. PubMed ID: 17274381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Co-operative on salvage chemotherapy with VP-16 for malignant lymphoma. Hanshin Study Group on Treatment for Hematological Disorders].
    Miyazaki E; Takemoto Y; Kanamaru A; Kakishita E; Nagai K; Masaoka T; Shibata H; Horiuti A; Tsubaki K; Yonezawa T
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):497-503. PubMed ID: 1558399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical trial of protocol-AL851 for children with high-risk acute lymphoblastic leukemia. Kyushu Yamaguchi Children's Cancer Study Group (KYCCSG)].
    Matsuzaki A; Ishii E; Ueda K; Yanai F; Nibu K; Take H; Koga H; Miyazaki S; Inoue T; Miyake K
    Rinsho Ketsueki; 1994 Sep; 35(9):862-70. PubMed ID: 7967055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [ABEP chemotherapy in the treatment of advanced non-Hodgkin's lymphomas].
    Yoshida T; Nakanishi J; Ito K; Kobayashi K; Ohtake S; Nakamura S; Matsuda T; Nakagoshi T; Natori K; Nakamura E
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):984-9. PubMed ID: 3963862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis.
    Hainsworth JD; Wolff SN; Stein RS; Greer JP; Cousar JB; Greco FA
    Cancer Treat Rep; 1986 Aug; 70(8):953-8. PubMed ID: 3015406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A phase III study of BHAC-MMP (behenoyl-ara-C, mitoxantrone, 6-mercaptopurine prednisolone) in acute leukemia. Hanshin Cooperative Study Group of Hematological Disorders].
    Masaoka T; Shibata H; Nagai K; Kanamaru A; Horiuchi A; Kitani T; Yonezawa T; Kawagoe H; Yasunaga K
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2829-34. PubMed ID: 3530140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of adult acute lymphoblastic leukemia with Ad-VP-L regimen].
    Umeda M; Shikoshi K; Anno S; Su CY; Shirai T
    Rinsho Ketsueki; 1991 Jan; 32(1):6-10. PubMed ID: 2020119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Aclacinomycin A and behenoyl ara-C combination chemotherapy for untreated acute non-lymphocytic leukemia].
    Sampi K; Honda T; Hayashi Y; Hattori M
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2211-6. PubMed ID: 6578705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [THP-COP, BHAC-VMP alternating chemotherapy in patients with non-Hodgkin's lymphoma].
    Imura H; Ito N; Shirakawa S; Sobue R; Maruyama F; Kojima H; Shinkai K; Matsui T; Ino T; Shimizu K
    Rinsho Ketsueki; 1988 May; 29(5):688-93. PubMed ID: 3216495
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment with ACVP-16 for relapsed and refractory non-Hodgkin's lymphoma].
    Niitsu N; Hara A; Umeda M; Shirai T
    Rinsho Ketsueki; 1993 Jul; 34(7):829-34. PubMed ID: 7689661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.